0001615219 2024-01-01 2024-12-31 0001615219 2023-01-01 2023-12-31 0001615219 2022-01-01 2022-12-31 0001615219 ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember ecd:PeoMember 2024-01-01 2024-12-31 0001615219 ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember ecd:PeoMember 2024-01-01 2024-12-31 0001615219 ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember ecd:PeoMember 2024-01-01 2024-12-31 0001615219 ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember ecd:PeoMember 2024-01-01 2024-12-31 0001615219 ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember ecd:PeoMember 2024-01-01 2024-12-31 0001615219 ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember ecd:PeoMember 2023-01-01 2023-12-31 0001615219 ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember ecd:PeoMember 2023-01-01 2023-12-31 0001615219 ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember ecd:PeoMember 2023-01-01 2023-12-31 0001615219 ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember ecd:PeoMember 2023-01-01 2023-12-31 0001615219 ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember ecd:PeoMember 2023-01-01 2023-12-31 0001615219 ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember ecd:PeoMember 2022-01-01 2022-12-31 0001615219 ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember ecd:PeoMember 2022-01-01 2022-12-31 0001615219 ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember ecd:PeoMember 2022-01-01 2022-12-31 0001615219 ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember ecd:PeoMember 2022-01-01 2022-12-31 0001615219 ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember ecd:PeoMember 2022-01-01 2022-12-31 0001615219 ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001615219 ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001615219 ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001615219 ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001615219 ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001615219 ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0001615219 ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0001615219 ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0001615219 ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0001615219 ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0001615219 ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember ecd:NonPeoNeoMember 2022-01-01 2022-12-31 0001615219 ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember ecd:NonPeoNeoMember 2022-01-01 2022-12-31 0001615219 ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember ecd:NonPeoNeoMember 2022-01-01 2022-12-31 0001615219 ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember ecd:NonPeoNeoMember 2022-01-01 2022-12-31 0001615219 ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember ecd:NonPeoNeoMember 2022-01-01 2022-12-31 0001615219 1 2024-01-01 2024-12-31 0001615219 2 2024-01-01 2024-12-31 0001615219 flks:MarkJ.RosenblumMember 2024-02-20 iso4217:USD shares iso4217:USD shares pure 0001615219 DEF 14A false Salarius Pharmaceuticals, Inc. true <div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.463%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.463%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.463%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.463%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.831%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.526%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom">Year </td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom">Summary Compensation Table for PEO(1)</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom">Compensation Actually Paid to PEO(2)(3)</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom">Average Summary Compensation Table Totals for non-PEO NEOs(1)</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom">Average Compensation Actually Paid to non-PEO NEO(2)(3)</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom">Value of Initial Fixed $100 Investment Based On: Total Shareholder Return</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom">Net Loss (in millions)</td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom">2024</td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom">$734,450</td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom">$727,586</td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom">$350,422</td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom">$343,233</td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom">$1.86</td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom">$5.58</td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom">2023</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom">$544,600</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom">$516,927</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom">$355,760</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom">$345,284</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom">$5.25</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom">$12.54</td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom">2022</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom">$941,023</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom">$609,104</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom">$494,554</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom">$383,431</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom">$12.35</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom">$31.61</td></tr></table></div> 734450 727586 350422 343233 1.86

5580000

544600 516927 355760 345284 5.25

12540000

941023 609104 494554 383431 12.35

31610000

The PEO for 2024, 2023 and 2022 is David Arthur. The Non-PEO NEO for whom the average compensation is presented in the table for 2024, 2023 and 2022 is Mark Rosenblum. David Arthur The amounts shown as Compensation Actually Paid (“CAP”) have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation actually realized or received by the Company’s PEO and Non-PEO NEO. These amounts reflect total compensation as set forth in the Summary Compensation Table for each year, adjusted as described in footnote 3 below.<div style="text-align:justify">We do not utilize TSR and net loss in our executive compensation program. However, we do utilize several other performance measures to align executive compensation with our performance. As described in more detail above in the section of Summary Compensation Tables and Employment Agreements, part of the compensation our NEOs are eligible to receive consists of annual performance-based cash bonuses that are designed to provide appropriate incentives to our executives to achieve defined annual corporate goals and to reward our executives for individual achievement towards these goals, subject to certain employment criteria. Additionally, we view stock options, which are an integral part of our executive compensation program, as related to company performance although not directly tied to TSR, because they provide value only if the market price of our common stock increases, and if the executive officer continues in our employment over the vesting period. These stock option awards strongly align our executive officers’ interests with those of our stockholders by providing a continuing financial incentive to maximize long-term value for our stockholders and by encouraging our executive officers to continue in our employment for the long-term.</div><div style="text-align:justify"> </div><div style="text-align:justify">With respect to net income, specifically, because we are not a commercial-stage company, we did not have any revenue during the periods presented, other than revenue associated with grants. Consequently, our company does not consider net loss as a performance measure for our executive compensation program. In 2024, our net loss decreased from 2023 and 2022, respectively. This decrease was primarily due to the fact that we have curtailed our sponsored clinical trials and intend to rely on clinical trial data from the investigator initiated clinical trial conducted by MD Anderson Cancer Center in connection with our strategic alternatives review process.</div> CAP reflects the exclusions and inclusions for the PEO and the Non-PEO NEO set forth below. Amounts excluded, which are set forth in the “Minus Stock and Option Awards from Summ. Comp. Table” columns below, represent the stock awards and option awards reported in the Stock Awards and Option Awards columns of the Summary Compensation Table for each applicable year. Amounts added back to determine CAP are made up of the following components which are set forth in the table below, as applicable: (i) the fair value as of the end of the fiscal year of outstanding and unvested equity awards granted in that year; (ii) the change in fair value during the year of equity awards granted in prior years that remained outstanding and unvested at the end of the year; (iii) the fair value as of the vesting date of equity awards that were granted and vested in that year; and (iv) the change in fair value during the year through the vesting date of equity awards granted in prior years that vested during that year. The fair value at the end of the prior year of awards granted in any prior year that failed to meet applicable vesting conditions during the covered year are subtracted. Equity values are calculated in accordance with ASC Topic 718.<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.046%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.721%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.915%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.123%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.158%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.282%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">Year</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">Summary Comp. Table Total for Other NEO</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">Minus Stock and Option Awards from Summ. Comp. Table</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">Plus Year-End Equity Value of Unvested Awards Granted During Year</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">Plus Change in Value of Unvested Awards Granted in Prior Years</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">Plus Value of Awards Granted and Vested During Year</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">Plus Change in Value of Prior Years’ Awards Vested During Year</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">Comp. Actually Paid to Other NEO</td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top">2024</td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top">$350,422</td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top">$11,372</td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top">$4,230</td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom">$(65)</td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top">$0</td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom">$18</td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom">$343,233</td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">2023</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">$355,760</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">$12,560</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">$5,200</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom">$(3,791)</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">$0</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom">$675</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom">$345,284</td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">2022</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">$494,554</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">$84,579</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">$8,210</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom">$(24,959)</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">$0</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom">$(9,795)</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom">$383,431</td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div> CAP reflects the exclusions and inclusions for the PEO and the Non-PEO NEO set forth below. Amounts excluded, which are set forth in the “Minus Stock and Option Awards from Summ. Comp. Table” columns below, represent the stock awards and option awards reported in the Stock Awards and Option Awards columns of the Summary Compensation Table for each applicable year. Amounts added back to determine CAP are made up of the following components which are set forth in the table below, as applicable: (i) the fair value as of the end of the fiscal year of outstanding and unvested equity awards granted in that year; (ii) the change in fair value during the year of equity awards granted in prior years that remained outstanding and unvested at the end of the year; (iii) the fair value as of the vesting date of equity awards that were granted and vested in that year; and (iv) the change in fair value during the year through the vesting date of equity awards granted in prior years that vested during that year. The fair value at the end of the prior year of awards granted in any prior year that failed to meet applicable vesting conditions during the covered year are subtracted. Equity values are calculated in accordance with ASC Topic 718.<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.646%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.722%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.672%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.134%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.393%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.077%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.440%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">Year</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">Summary Comp. Table Total for PEO</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">Minus Stock and Option Awards from Summ. Comp. Table</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">Plus Year-End Equity Value of Unvested Awards Granted During Year</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">Plus Change in Value of Unvested Awards Granted in Prior Years</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">Plus Value of Awards Granted and Vested During Year</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">Plus Change in Value of Prior Years’ Awards Vested During Year</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">Comp. Actually Paid to PEO</td><td colspan="15" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top">2024</td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top">$734,450</td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top">$8,265</td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top">$1,522</td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top">($163)</td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top">$0</td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top">$42</td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top">$727,586</td><td colspan="15" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">2023</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">$544,600</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">$31,400</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">$13,000</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">($10,395)</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">$0</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">$1,122</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">$516,927</td><td colspan="15" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">2022</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">$941,023</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">$211,448</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">$20,526</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">($101,823)</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">$0</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">($39,174)</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top">$609,104</td><td colspan="15" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:0 1pt"></td></tr></table></div> 734450 -8265 1522 -163 0 42 727586 544600 -31400 13000 -10395 0 1122 516927 941023 -211448 20526 -101823 0 -39174 609104 350422 -11372 4230 -65 0 18 343233 355760 -12560 5200 -3791 0 675 345284 494554 -84579 8210 -24959 0 -9795 383431 <div style="text-align:justify">In accordance with Item 402(v) of Regulation S-K, we are providing the following descriptions of the relationships between information presented in the Pay Versus Performance table on CAP and each of total stockholder return (“TSR”) and net loss.</div> TSR net loss <div style="text-align:justify">The following graph illustrates the relationship during 2022-2024 of the CAP for our PEO and non-PEO NEO as calculated pursuant to SEC rules to our TSR assuming a $100 investment in our stock on December 31, 2021.</div><div style="text-align:center"><img alt="1.jpg" id="i-1" src="flks-20251107_g1.jpg" style="height:257px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/></div> <div>The following graph illustrates the relationship during 2022-2024 of the CAP for our CEO and other NEOs as calculated pursuant to SEC rules to our net loss.</div><div style="margin-bottom:12pt;margin-top:12pt"><img alt="2.jpg" id="i-2" src="flks-20251107_g2.jpg" style="height:284px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/></div> <div style="margin-bottom:12pt;margin-top:12pt;text-align:justify">We do not have any formal policy that requires us to grant, or avoid granting, equity-based compensation to our executive officers at certain times. Consistent with its annual compensation cycle, the Compensation Committee has for several years granted annual equity awards to our executive officers in February of each year. The timing of any equity grants to executive officers in connection with new hires, promotions, or other non-routine grants is tied to the event giving rise to the award (such as an executive officer’s commencement of employment or promotion effective date). As a result, in all cases, the timing of grants of equity awards, including stock options, occurs independent of the release of any material nonpublic information, and we do not time the disclosure of material nonpublic information for the purpose of affecting the value of equity-based compensation. </div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify">The following table presents information regarding stock options issued to certain of our executive officers in 2024 during any period beginning four business days before the filing of a periodic report or current report disclosing material non-public information and ending one business day after the filing or furnishing of such report with the SEC. </div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.406%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.253%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.320%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.476%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.369%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.476%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.521%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.235%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.082%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.903%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom">Name</td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom">Grant Date</td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom">Number of Securities Underlying the Award</td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:bottom">Exercise Price of the Award</td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:bottom">Grant Date Fair Value of the Award</td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom">Percentage Change in the Closing Market Price of the Securities Underlying the Award Between the Trading Day Ending Immediately Prior to the Disclosure of Material Nonpublic Information and the Trading Day Beginning Immediately Following the Disclosure of Material Nonpublic Information</td></tr><tr><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom">Mark J. Rosenblum</td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom">02/20/2024</td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom">188</td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom">$65.532</td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom">$11,372</td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom">3.2%</td></tr></table></div> We do not have any formal policy that requires us to grant, or avoid granting, equity-based compensation to our executive officers at certain times. Consistent with its annual compensation cycle, the Compensation Committee has for several years granted annual equity awards to our executive officers in February of each year. The timing of any equity grants to executive officers in connection with new hires, promotions, or other non-routine grants is tied to the event giving rise to the award (such as an executive officer’s commencement of employment or promotion effective date). As a result, in all cases, the timing of grants of equity awards, including stock options, occurs independent of the release of any material nonpublic information, and we do not time the disclosure of material nonpublic information for the purpose of affecting the value of equity-based compensation. false Consistent with its annual compensation cycle, the Compensation Committee has for several years granted annual equity awards to our executive officers in February of each year. The timing of any equity grants to executive officers in connection with new hires, promotions, or other non-routine grants is tied to the event giving rise to the award (such as an executive officer’s commencement of employment or promotion effective date). true false <div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.406%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.253%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.320%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.476%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.369%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.476%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.521%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.235%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.082%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.903%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom">Name</td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom">Grant Date</td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom">Number of Securities Underlying the Award</td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:bottom">Exercise Price of the Award</td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:bottom">Grant Date Fair Value of the Award</td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom">Percentage Change in the Closing Market Price of the Securities Underlying the Award Between the Trading Day Ending Immediately Prior to the Disclosure of Material Nonpublic Information and the Trading Day Beginning Immediately Following the Disclosure of Material Nonpublic Information</td></tr><tr><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom">Mark J. Rosenblum</td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom">02/20/2024</td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom">188</td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom">$65.532</td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom">$11,372</td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom">3.2%</td></tr></table></div> Mark J. Rosenblum 188 65.532 11372 0.032